Anti-inflammatory medicaments
US7342037B2 · kind B2 · utility
65Cited by
11References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2006 |
| Grant date | Mar 11, 2008 |
| Priority date | — |
| Expiry date | Jun 9, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds and methods of using those compounds for the treatment of inflammatory conditions are provided. In a preferred embodiment, modulation of the activation state of p38 kinase protein comprises the step of contacting the kinase protein with the novel compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.